| 1 |
Recurrent noncirrhotic hyperammonemia causing acute metabolic encephalopathy in a patient with a continent ileocecal pouch: a case report |
|
|
| T. M. Skipina, S. Macbeth, E. L. Cummer, O. L. Wells, S. Kalathoor |
|
| Journal of Medical Case Reports. 2021; 15(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Topiramate-induced hyperammonemic encephalopathy in a patient with mental retardation: A case report and review of the literature |
|
|
| Sahawat Tantikittichaikul,Justine Johnson,Pavis Laengvejkal,John DeToledo |
|
| Epilepsy & Behavior Case Reports. 2015; 4: 84 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Efficacy and Safety of Intravenous Valproate for Status Epilepticus: A Systematic Review |
|
|
| Eugen Trinka,Julia Höfler,Alexander Zerbs,Francesco Brigo |
|
| CNS Drugs. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Valproic acid and epilepsy: From basic research to clinical findings (Chapter ) |
|
|
| Rossetti, F., Furtado, M.A., Yourick, D.L. |
|
| Valproic Acid: Pharmacology, Mechanisms of Action and Clinical Implications. 2013; |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Valproic Acid and Topiramate Induced Hyperammonemic Encephalopathy in a Patient With Normal Serum Carnitine |
|
|
| Martha G. Blackford,Stephanie T. Do,Thomas C. Enlow,Michael D. Reed |
|
| The Journal of Pediatric Pharmacology and Therapeutics. 2013; 18(2): 128 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Valproate induced carnitine deficiency - Pathobiochemistry and clinical consequences | [Valproinsäure-induziertes carnitin-defizit: Pathobiochemie und klinische konsequenzen] |
|
|
| Ströhle, A. |
|
| Psychopharmakotherapie. 2012; 19(1): 3-9 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Topiramate-Valproate-Induced Encephalopathy in Migraine |
|
|
| Rahul T. Chakor,Haresh S. Bharote |
|
| Headache: The Journal of Head and Face Pain. 2012; 52(8): 1321 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Encefalopatía hiperamonémica asociada a ácido valproico por posible sinergismo con fenobarbital y topiramato: comunicación de tres casos |
|
|
| A. Cano-Zuleta,O.H. Hernández-Ortíz,C.A. González-González,P. Amariles |
|
| Farmacia Hospitalaria. 2012; 36(5): 441 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Hyperammonemic encephalopathy related to valproate, phenobarbital, and topiramate synergism |
|
|
| Asier Gomez-Ibañez,Elena Urrestarazu-Bolumburu,Cesar Viteri-Torres |
|
| Epilepsy & Behavior. 2011; 21(4): 480 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Hyperammonemic encephalopathy related to valproate, phenobarbital, and topiramate synergism |
|
|
| Gomez-Ibañez, A., Urrestarazu-Bolumburu, E., Viteri-Torres, C. |
|
| Epilepsy and Behavior. 2011; 21(4): 480-482 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Antiepileptic drug-induced encephalopathy |
|
|
| Sun, H., Wang, X. |
|
| Chinese Journal of Contemporary Neurology and Neurosurgery. 2011; 1(4): 380-385 |
|
| [Pubmed] [Google Scholar] |
|
